Who makes Doxycycline and S-equol?

Doxycycline and S-equol is developed by Nexgen Dermatologics, Inc..

What development phase is Doxycycline and S-equol in?

Doxycycline and S-equol is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Doxycycline and S-equol

Nexgen Dermatologics, Inc. · Phase 1 active Small molecule

At a glance

Generic name	Doxycycline and S-equol
Sponsor	Nexgen Dermatologics, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Doxycycline and S-equol CI brief — competitive landscape report
Doxycycline and S-equol updates RSS · CI watch RSS
Nexgen Dermatologics, Inc. portfolio CI